Flu drugs are a new clinical trial that successfully causes fever

1. Successfully manufactured new medicine helps treat rare immune diseases
2. Medical mystery: The girl miraculously revived after a night of freezing

International researchers have just announced that they have successfully tested the first phase of a new, extremely effective and safe anti-influenza drug, radavirsen.

According to a study published in the Journal of Clinical Pharmacology, a total of 56 people who have been clinically tested with radavirsen drugs, belonging to the antisense oligomer strain are able to block the production and development of influenza virus proteins.

"This is the first time that the radavirsen drug of the antisense oligomer strain has been shown to be easily tolerated, safe, and has a good pharmacokinetic ability to treat influenza A," the researchers wrote .

Previously, scientists also screened 66 healthy people, 56 people directly involved in the study between 2013 and 2015, each dose was given between 0.5 and 8 mg of flu, the remaining it is a placebo.

The initial test results showed that 74% of people who received the radavirse vaccine were safe, the flu improved thoroughly but with 94% of the placebo group, they did not get the flu, or slowed down by self-elimination.

In parallel, a new sideline study showed that the major side effects of radavirsen were headache and proteinuria.

In general, the researchers confirmed that radavirsen was thought to be very safe and well tolerated by the majority of the study participants, recommending that other tests be conducted to test effectiveness. of this drug further in the treatment for influenza patients.